Teva Pharma Industries Ltd
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +17.1% | -0.1% | +14.9% | +36.5% | +18.7% | +21.2% | +30.1% | +46.5% | +9.4% | +60.1% | +11.9% | +17.8% | +25.4% | +16.0% | +13.6% | +10.9% | 0.0% | -0.2% | -3.1% | +11.5% | +2.2% | -15.8% | -10.4% | -1.4% | -4.7% | -6.0% | +6.2% | +4.4% | +4.3% | |
| – | +14.3% | +1.1% | +9.9% | +37.7% | +27.7% | +15.7% | +23.5% | +45.6% | +8.2% | +49.8% | +9.2% | +12.9% | +27.7% | +8.0% | +24.7% | +9.9% | -0.6% | -4.1% | -10.0% | +21.1% | +15.1% | -8.7% | -11.4% | -4.5% | -7.3% | -4.0% | +3.1% | +3.4% | -1.9% | |
| – | +21.0% | -1.7% | +21.6% | +34.9% | +7.7% | +29.3% | +38.7% | +47.4% | +10.8% | +71.7% | +14.5% | +22.4% | +23.4% | +23.0% | +5.0% | +11.9% | +0.5% | +3.3% | +2.7% | +4.4% | -8.7% | -23.4% | -9.2% | +2.5% | -1.7% | -8.2% | +9.6% | +5.5% | +10.9% | |
| – | +3.8% | +4.4% | +20.2% | +27.8% | +2.6% | +53.8% | +29.4% | +58.5% | +9.0% | +34.2% | +17.4% | +35.3% | +2.0% | +16.3% | +17.4% | +23.8% | +5.2% | +4.3% | +2.5% | +38.4% | -12.5% | -34.4% | -16.7% | +77.6% | -39.0% | -23.4% | +13.7% | +10.7% | -4.0% | |
| – | – | – | – | – | +14.4% | +21.4% | +28.5% | +41.0% | -80.9% | +944.1% | +20.1% | -73.0% | +23.0% | +5.1% | +7.7% | +32.8% | +0.1% | -1.8% | +1.8% | -0.2% | +7.6% | -2.4% | -8.2% | -1.6% | -6.3% | +7.4% | -1.5% | -0.1% | +10.9% | |
| – | +14.6% | +6.6% | +14.7% | +7.2% | +14.4% | +21.4% | +11.0% | +67.9% | +9.7% | +85.2% | +14.7% | +94.3% | -10.8% | +10.8% | +15.5% | +17.6% | +4.2% | -2.7% | -4.9% | +15.5% | -5.2% | -20.6% | +47.0% | +41.6% | -48.0% | +56.0% | -51.5% | +88.0% | -19.0% | |
| – | +34.4% | -16.6% | +37.3% | +22.8% | +47.5% | +45.2% | +67.4% | -34.1% | +127.2% | -39.0% | +199.0% | -52.2% | +110.0% | +61.0% | -19.7% | -29.1% | -25.2% | +139.6% | -15.2% | -35.7% | -911.7% | – | – | – | – | -228.0% | – | -170.0% | – | |
| – | -6.7% | +56.9% | -34.1% | +335.4% | -77.7% | -61.0% | +378.0% | +1,396.9% | -99.6% | +61,309.1% | -95.9% | +183.9% | -27.7% | -2.2% | -32.0% | +132.0% | -20.6% | -2.1% | +68.5% | +186.0% | -32.7% | -1.6% | +8.6% | -21.1% | +18.0% | +4.4% | +10.6% | -8.6% | -2.7% | |
| – | +48.7% | -28.9% | +62.7% | +28.3% | +64.4% | +46.1% | +74.7% | -30.8% | +116.8% | -46.0% | +233.3% | -64.9% | +166.4% | +65.5% | -18.9% | -38.5% | -31.3% | +191.0% | -35.3% | -65.0% | -2,330.5% | – | – | – | – | -571.1% | – | – | – | |
| – | +85.2% | -20.2% | +43.5% | +34.4% | +6.9% | +33.2% | +114.0% | +47.2% | -11.6% | -34.4% | +156.1% | -53.4% | -10.3% | +70.5% | -55.1% | -207.9% | – | – | +7.3% | -17.8% | -471.0% | – | – | -39.6% | +25.6% | -404.7% | – | – | -126.6% | |
| – | +38.3% | -32.2% | +71.3% | +26.0% | +87.5% | +47.5% | +68.4% | -52.0% | +223.2% | -49.1% | +257.5% | -67.5% | +215.0% | +66.6% | -17.2% | -28.9% | -35.4% | +140.7% | -48.0% | -79.3% | -5,043.8% | – | – | – | – | -686.6% | – | – | – | |
| – | +30.5% | +16.2% | +28.0% | +40.0% | +3.3% | +7.9% | +93.2% | +37.6% | +11.6% | +62.5% | -5.2% | -31.6% | +46.8% | +100.6% | -11.7% | -8.9% | -17.4% | +86.3% | +6.1% | -54.8% | -641.4% | – | +2,286.0% | +3.9% | -4.4% | -121.0% | – | +923.3% | -29.1% |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.